Cancer Research (BK2573) Stock Forum and Discussion

Cancer Research Watchlist

Cancer Research includes companies working on scientific research aimed at understanding the causes, prevention, diagnosis, treatment, and potential cures for cancer. It includes many disciplines, from biology and genetics, to clinical trials and drug development, with the ultimate goal of improving cancer care and outcomes. Cancer research companies are developing life-saving treatments and diagnostics for a growing market in high demand. These companies constantly innovate, have a global reach, and form important strategic partnerships, which makes them appealing to investors looking for profits and supporting health progress.

1161.611
+2.535+0.22%

Close Mar 31 16:00 ET

1165.121High1146.159Low

Constituent Stocks: 9Top Rising: BMY+1.62%

Teddy123

54 minutes ago

Organon Acquires TOFIDENCE™ (tocilizumab-bavi), a Commercialized Biosimilar to ACTEMRA® (tocilizumab) Injection, for Intravenous Infusion in the U.S.

$Organon & Co (OGN.US)$ $Biogen (BIIB.US)$
Organon Claims US Market Leadership with Groundbreaking Tocilizumab Biosimilar Deal

Investing with moomoo

2 hours ago

Columns The Whole World Is Waiting for Trump to Wield the Tariff Stick. Here's What You Need to Know

President Donald Trump is gearing up to unveil a significant new set of import tariffs, which he refers to as “Liberation Day,”scheduled to commence this Wednesday (or Tuesday evening). The forthcoming announcement is poised to significantly intensify Trump's ongoing trade conflicts globally, with detailed information expected to be disclosed shortly.
On Monday, Trump suggested that he would be “very kind...

Trump tariff ‘lift’ nears: Will trade reshaping create new investment opportunities?

Teddy123

22 hours ago

WINREVAIR™ (sotatercept-csrk) Reduced the Risk of a Composite of All-Cause Death, Lung Transplantation and Hospitalization for Pulmonary Arterial Hypertension (PAH) by 76% Compared to Placebo in the

$Merck & Co (MRK.US)$
Landmark Trial: Merck's New PAH Drug Shows Stunning 76% Reduction in Life-Threatening Events

Teddy123

Yesterday 18:09

Exact Sciences Launches the Cologuard Plus™ Test, Transforming Colorectal Cancer Screening

$Exact Sciences (EXAS.US)$
Revolutionary Cancer Test Achieves 95% Accuracy, Cuts Unnecessary Procedures by 40%

MonkeyGee

Mar 29 12:59

Sorry, no profit corn this week.

follow me if you like profit corn.

Share Your Profit/Loss

Hazemism

Mar 29 00:53

$Merck & Co (MRK.US)$ thats my boy waking up

Deep Sea

Mar 28 23:27

$Pfizer (PFE.US)$
Seems like PFE has hit the bottom at 24.81. Stock is staging a rebound.

Demon Town

Mar 28 23:11

$Pfizer (PFE.US)$ Sold all Haleon shares, Sudden +125M shorts, new weight loss drug results about to be released, and Q1 data nearly ready—everything happened simultaneously, yet no one seems to have a clear explanation. Something BIG coming?

Teddy123

Mar 28 20:55

Bristol Myers Squibb Receives Positive CHMP Opinion for Perioperative Regimen of Neoadjuvant Opdivo® (nivolumab) and Chemotherapy Followed by Surgery and Adjuvant Opdivo for Resectable Non-Small Cell

$Bristol-Myers Squibb (BMY.US)$
Major Breakthrough: New Opdivo Treatment Regime Shows Promise for Early-Stage Lung Cancer Patients

Teddy123

Mar 28 20:15

Bristol Myers Squibb Receives Positive CHMP Opinion for the Subcutaneous Formulation of Opdivo® (nivolumab) Across Multiple Solid Tumor Indications

$Bristol-Myers Squibb (BMY.US)$
Breakthrough: BMY's New Subcutaneous Cancer Drug Shows Superior Results Across Tumors

No comment yet